Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Cells
|
February 9, 2024
Integrins in Health and Disease-Suitable Targets for Treatment?
Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Chemical Science
|
October 8, 2019
A general concept for the introduction of hydroxamic acids into polymers
Tobias Johann, Jennifer Keth, Matthias Bros, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2014
Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB
Stefanie Trojandt, Angelika B Reske-Kunz, Matthias Bros
Cells
|
September 12, 2020
Nucleic Acid-Based Approaches for Tumor Therapy
Simone Hager, Frederic Julien Fittler, Ernst Wagner, et al.
Gene
|
October 24, 2007
The untranslated region of exon 2 of the human neuronal nitric oxide synthase (NOS1) gene exerts regulatory activity
Matthias Bros, Jean-Paul Boissel, Ute Gödtel-Armbrust, et al.
Cancers
|
April 12, 2022
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, Thomas Jung, et al.
International Immunopharmacology
|
April 13, 2016
The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10
Matthias Bros, Evelyn Montermann, Anna Cholaszczyńska, et al.
International Journal of Molecular Sciences
|
September 28, 2021
Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond
Thomas Jung, Maximilian Haist, Michael Kuske, et al.
Genomics
|
January 18, 2006
Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences
Matthias Bros, Jean-Paul Boissel, Ute Gödtel-Armbrust, et al.
Human Immunology
|
September 6, 2016
Tumor-derived immuno-modulators induce overlapping pro-tolerogenic gene expression signatures in human dendritic cells
Stefanie Trojandt, Iris Bellinghausen, Angelika B Reske-Kunz, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Cells
|
February 9, 2024
Integrins in Health and Disease-Suitable Targets for Treatment?
Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Chemical Science
|
October 8, 2019
A general concept for the introduction of hydroxamic acids into polymers
Tobias Johann, Jennifer Keth, Matthias Bros, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2014
Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB
Stefanie Trojandt, Angelika B Reske-Kunz, Matthias Bros
Cells
|
September 12, 2020
Nucleic Acid-Based Approaches for Tumor Therapy
Simone Hager, Frederic Julien Fittler, Ernst Wagner, et al.
Gene
|
October 24, 2007
The untranslated region of exon 2 of the human neuronal nitric oxide synthase (NOS1) gene exerts regulatory activity
Matthias Bros, Jean-Paul Boissel, Ute Gödtel-Armbrust, et al.
Cancers
|
April 12, 2022
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, Thomas Jung, et al.
International Immunopharmacology
|
April 13, 2016
The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10
Matthias Bros, Evelyn Montermann, Anna Cholaszczyńska, et al.
International Journal of Molecular Sciences
|
September 28, 2021
Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond
Thomas Jung, Maximilian Haist, Michael Kuske, et al.
Genomics
|
January 18, 2006
Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences
Matthias Bros, Jean-Paul Boissel, Ute Gödtel-Armbrust, et al.
Human Immunology
|
September 6, 2016
Tumor-derived immuno-modulators induce overlapping pro-tolerogenic gene expression signatures in human dendritic cells
Stefanie Trojandt, Iris Bellinghausen, Angelika B Reske-Kunz, et al.
Page
of 13